On January 8, 2024, Liquidia Corporation closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 USD | -2.65% | -5.09% | +3.91% |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
Apr. 01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.91% | 981M | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Liquidia Corporation announced that it has received $74.999999 million in funding from Legend Aggregator, LP